HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice.

Abstract
Scavenger receptor class B type I (SR-BI)-deficient mice display reduced survival to endotoxic shock and sepsis. The understanding of the mechanisms underlying SR-BI protection has been hampered by the large spectrum of SR-BI functions and ligands. It notably plays an important role in the liver in high-density lipoprotein metabolism, but it is also thought to participate in innate immunity as a pattern recognition receptor for bacterial endotoxins, such as LPS. In this study, we sought to determine the tissue-specific contribution of SR-BI in the hyperinflammatory response and high mortality rates observed in SR-BI(-/-) mice in endotoxicosis or sepsis. Restoring plasma levels of high-density lipoprotein, which are critical lipoproteins for LPS neutralization, did not improve acute outcomes of LPS injection in SR-BI(-/-) mice. Mice deficient for SR-BI in hepatocytes, endothelial cells, or myeloid cells were not more susceptible to LPS-induced death. However, if SR-BI ablation in hepatocytes led to a moderate increase in systemic inflammatory markers, SR-BI deficiency in myeloid cells was associated with an anti-inflammatory effect. Finally, mice deficient for SR-BI in the adrenal cortex, where the receptor provides lipoprotein-derived cholesterol, had impaired secretion of glucocorticoids in response to stress. When exposed to an endotoxin challenge, these mice exhibited an exacerbated systemic and local inflammatory response, reduced activation of atrophy genes in muscle, and high lethality rate. Furthermore, polymicrobial sepsis induced by cecal ligature and puncture resulted in early death of these animals. Our study clearly demonstrates that corticoadrenal SR-BI is a critical element of the hypothalamic-pituitary-adrenal axis to provide effective glucocorticoid-dependent host defense after an endotoxic shock or bacterial infection.
AuthorsSophie Gilibert, Lauriane Galle-Treger, Martine Moreau, Flora Saint-Charles, Sara Costa, Raphaëlle Ballaire, Philippe Couvert, Alain Carrié, Philippe Lesnik, Thierry Huby
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 193 Issue 2 Pg. 817-26 (Jul 15 2014) ISSN: 1550-6606 [Electronic] United States
PMID24935924 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 by The American Association of Immunologists, Inc.
Chemical References
  • Cholesterol, LDL
  • Interleukin-6
  • Lipopolysaccharides
  • Scarb1 protein, mouse
  • Scavenger Receptors, Class B
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
Topics
  • Adrenal Cortex (immunology, metabolism)
  • Animals
  • Cholesterol, LDL (blood, immunology, metabolism)
  • Endothelial Cells (drug effects, immunology, metabolism)
  • Flow Cytometry
  • Gene Expression (drug effects, immunology)
  • Hepatocytes (drug effects, immunology, metabolism)
  • Interleukin-10 (blood, immunology, metabolism)
  • Interleukin-6 (blood, immunology, metabolism)
  • Lipopolysaccharides (immunology, toxicity)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microscopy, Fluorescence
  • Muscle, Skeletal (drug effects, immunology, metabolism)
  • Myeloid Cells (drug effects, immunology, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Scavenger Receptors, Class B (deficiency, genetics, immunology)
  • Sepsis (immunology, microbiology, mortality)
  • Shock, Septic (immunology, microbiology)
  • Spleen (drug effects, immunology, metabolism)
  • Survival Analysis
  • Survival Rate
  • Tumor Necrosis Factor-alpha (blood, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: